Gapping down
In reaction to earnings/guidance:
- MANU -1.8%, USNA -0.8% (guides Q3 revs below single est, lowers FY21 guidance; increases share repurchase program)
Other news:
- PTGX -50.7% (receives Clinical Hold from FDA on Rusfertide clinical development program)
- TPB -4.8% (receives MDO on PMTA process)
- X -2.1% (announces exploratory site selection process to build new $3 bln mini mill in the US; also guides EBITDA slightly above consensus)
- SGMS -1.5% (names new CFO)
- GRFS -1.5% (entered into a share purchase agreement with Tiancheng International Investment Limited)
- CARR -1% (to acquire BrokerBay)
Analyst comments:
- CRUS -3% (downgraded to Underperform from Neutral at BofA Securities)
- CREE -2.8% (downgraded to Underperform from Neutral at BofA Securities)
- EQNR -1.3% (downgraded to Underweight from Neutral at JP Morgan)